Anjali V. Sheahan

ONECUT2 is a driver of neuroendocrine prostate cancer

Haiyang Guo, Xinpei Ci, Musaddeque Ahmed et al. · Nature Communications · 2019 · 244 citations · Full text

Medicine, Molecular Biology, Oncology +17

EZH2 inhibition activates a dsRNA–STING–interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer

Katherine L. Morel, Anjali V. Sheahan, Deborah L. Burkhart et al. · Nature Cancer · 2021 · 241 citations · Full text

Medicine, Molecular Biology, Oncology +12

Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancer

Sylvan C. Baca, David Y. Takeda, Ji-Heui Seo et al. · Nature Communications · 2021 · 170 citations · Full text

Life Sciences, Genetics, Oncology +17

CREB5 Promotes Resistance to Androgen-Receptor Antagonists and Androgen Deprivation in Prostate Cancer

Justin H. Hwang, Ji-Heui Seo, Michael L. Beshiri et al. · Cell Reports · 2019 · 79 citations · Full text

Medicine, Oncology, Pharmacology +17

Targeting RET Kinase in Neuroendocrine Prostate Cancer

Halena R. VanDeusen, Johnny R. Ramroop, Katherine L. Morel et al. · Molecular Cancer Research · 2020 · 51 citations · Full text

Medicine, Oncology, Pharmacology +17